SKINOVATION PHARMACEUTICAL INCORPORATED: capital expenditure payments
Capital expenditure payments for SKINOVATION PHARMACEUTICAL INCORPORATED. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All SKINOVATION PHARMACEUTICAL INCORPORATED financial histories
What this measure means
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
Exact concept: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-01-01 to 2012-12-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Reading these values
The selected USD history reports 0 at all 3 reporting ends. These are reported zeros, not values substituted for missing data. This describes this concept and the selected periods only; it does not establish that other measures or later periods are unchanged.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2012-01-01 | 2012-12-31 | 0 | USD | 2013-03-27 | 10-K · 0001548123-13-000077 |
| 2011-01-01 | 2011-12-31 | 0 | USD | 2013-03-27 | 10-K · 0001548123-13-000077 |
| 2010-01-01 | 2010-12-31 | 0 | USD | 2012-03-30 | 10-K · 0001010412-12-000148 |
Related financial histories
- SKINOVATION PHARMACEUTICAL INCORPORATED: total assets
- SKINOVATION PHARMACEUTICAL INCORPORATED: total liabilities
- SKINOVATION PHARMACEUTICAL INCORPORATED: stockholders equity
- SKINOVATION PHARMACEUTICAL INCORPORATED: cash and cash equivalents
- SKINOVATION PHARMACEUTICAL INCORPORATED: net income or loss
- SKINOVATION PHARMACEUTICAL INCORPORATED: operating cash flow
- SKINOVATION PHARMACEUTICAL INCORPORATED: revenue
- SKINOVATION PHARMACEUTICAL INCORPORATED: financing cash flow
- SKINOVATION PHARMACEUTICAL INCORPORATED: retained earnings or deficit
- SKINOVATION PHARMACEUTICAL INCORPORATED: basic earnings per share
- SKINOVATION PHARMACEUTICAL INCORPORATED: operating income or loss
- SKINOVATION PHARMACEUTICAL INCORPORATED: current assets
- SKINOVATION PHARMACEUTICAL INCORPORATED: interest expense
- SKINOVATION PHARMACEUTICAL INCORPORATED: current liabilities
- SKINOVATION PHARMACEUTICAL INCORPORATED: current accounts payable
- SKINOVATION PHARMACEUTICAL INCORPORATED: operating expenses
- SKINOVATION PHARMACEUTICAL INCORPORATED: cash including restricted cash
- SKINOVATION PHARMACEUTICAL INCORPORATED: general and administrative expense
- SKINOVATION PHARMACEUTICAL INCORPORATED: other nonoperating income or expense
- SKINOVATION PHARMACEUTICAL INCORPORATED: change in accounts payable
Inspect the source
- Entity
- SKINOVATION PHARMACEUTICAL INCORPORATED / CIK 0001118072
- Captured
- 2026-09-21T17:18:22.262Z
- SEC response SHA-256
2a8f12373902fb089789064a50866081690b54ca91a66a8d71a686a973e9e781
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001118072.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))